Delivery Order SPE2DE21D0017-SPE2D626F28P2
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a $5,616.00 delivery order award on October 28, 2025, for the procurement of Alere ID NOW Flu A/B2 Qualified Detect Virus kits. The contract is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of November 4, 2025. Funding originates from the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain on August 7, 2025, for ID NOW flu diagnostic testing products. The contract, which carries no set-aside designation, indicates open competition and is scheduled for ultimate completion on August 14, 2025. Performance will occur at the vendor's location in Lockhart, Florida. This...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a $1,200 fixed-price delivery order with economic price adjustment from the Defense Logistics Agency Medical Supply Chain on April 28, 2025, for ID NOW flu diagnostic tests. The contract, awarded without set-aside designation through open competition, is designated as delivery order 4568059894 and carries an ultimate completion date of May 5, 2025. Performance will be executed at the contractor's location in...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $10,200 delivery order on July 24, 2025, for ID NOW flu tests under contract 4568885102. This fixed-price delivery order with economic price adjustment has an ultimate completion date of July 31, 2025, and will be performed in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. The funding agency is the Defense Logistics Agency (DLA) Medical Supply Chain,...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. specializing in medical diagnostic equipment and testing supplies, was awarded a delivery order valued at $9,360.00 by the Defense Logistics Agency Medical Supply Chain on September 16, 2025, for ID NOW flu tests. The contract is structured as a fixed-price delivery order with economic price adjustment and carries an ultimate completion date of September 23, 2025. This award was made without a set-aside designation,...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $6,360 fixed-price delivery order on December 16, 2025, with an ultimate completion date of December 23, 2025, for a kit ID NOW strip A2 qualitative detector mobile test. The award was issued by the Defense Logistics Agency Medical Supply Chain, a component of the Department of Defense, with performance to occur in Lake Mary, Florida. This delivery order represents a non-competitive award issued under an...
- This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The $2,208.00 fixed-price with economic price adjustment delivery order is for the ID NOW FLU product, which is a medical diagnostic testing device. The contract has an ultimate completion date of May 2, 2025 and was awarded on April 25, 2025. This award is not associated with a set-aside designation. Abbott Rapid DX North...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain unit to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide the ID NOW FLU testing system. The $43,200.00 fixed-price contract with economic price adjustment has an ultimate completion date of October 31, 2024. The award does not have a set-aside designation. Abbott Rapid DX North America LLC, doing business as Alere North America LLC, is a major supplier of COVID-19...
- The U.S. federal government awarded a $7,200.00 fixed-price delivery order contract with economic price adjustment to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide 4565764771 ! ID NOW FLU medical supplies. The contract, which does not have a set-aside designation, supports the Defense Logistics Agency Troop Support Medical and is set to be completed by September 16, 2024. Abbott Rapid DX North America LLC, a for-profit organization, is a major supplier of...
- This federal contract award, with ID SPE2DE21D0017|SPE2D624F6X4T, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The $43,200.00 fixed-price with economic price adjustment delivery order is for the supply of 4564728806 ID NOW FLU diagnostic products, without any set-aside designation. Abbott Rapid DX North America LLC, doing business as Alere North America LLC, is a major supplier...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D626F28P2Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $6,000 fixed-price delivery order with economic price adjustment on December 16, 2025, for Alere ID NOW Flu A/B2 Qualified Detect Virus kits. The contract, issued without set-aside designation, carries an ultimate completion date of December 23, 2025, and will be performed in Lake Mary, Florida. The Defense Logistics Agency Medical Supply Chain funded this award, which represents a delivery order against an existing indefinite delivery vehicle contract supporting federal healthcare procurement of diagnostic testing supplies. The ID NOW rapid diagnostic platform represents Abbott's point-of-care testing capabilities for influenza detection, supporting the government's clinical and medical readiness objectives. Abbott Rapid DX has established itself as a critical supplier to federal healthcare agencies including the Department of Defense, Veterans Administration, and Defense Health Agency through an extensive portfolio of diagnostic equipment and testing supplies. This award aligns with the company's broader federal contracting activities, which have historically centered on COVID-19 antigen tests, molecular diagnostic platforms, chemistry analyzers, and related clinical testing technologies delivered through delivery orders and blanket purchase agreements across multiple federal healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 12/15/25 |